Johan Vansteenkiste, MD, PhD of University Hospitals Leuven, Belgium talks about how patients with squamous cell carcinoma of the lung…
Browsing: Acute Lymphoblastic Leukemia
Lung Cancer Patient/Activist Janet Freeman-Daily talks about the successes of targeted therapies and immunotherapies in lung cancer. From a personal…
Hossein Borghaei, DO, MS of Fox Chase Cancer Center, Philadelphia, PA gives an outline of his talk on the different…
Frank Griesinger, MD, PhD from the Pius-Hospital Oldenburg, Oldenburg, Germany discusses the role of p53 mutation in EGFR mutation positive…
David Currow, PhD, MPH, FRACP, FAChPM, FAHMS, GAICD of Flinders University, Adelaide, Australia talks about his poster at the 2016…
Charlotta Pisinger, PhD, MD, MPH of the Rigshospitalet, Copenhagen, Denmark discusses e-cigarettes and their impact on health. She talks about…
Charles Rudin MD, PhD of the Memorial Sloan Kettering Cancer Center, New York, NY discusses targeted therapies, immunotherapy and their…
Beth Eaby-Sandy MSN, CRNP, OCN, of the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA explains the different toxicities seen…
Barbara Melosky, MD, FRCPC, of the University of British Columbia, Vancouver, BC discusses how the world of epidermal growth factor…
Ales Ryska, MD, PhD, of the Charles University, Medical Faculty Hospital, Prague, Czech Republic gives an overview of a session…
At ASH 2016, MPN experts from across the nation share their perspective on what the future holds for MPNs, in…
It is an honor and a privilege to be selected to present at the American Society of Hematology Conference. Dr.…
It is an honor and a privilege to be selected to present at the American Society of Hematology Conference. Dr.…
It is an honor and a privilege to be selected to present at the American Society of Hematology Conference. Dr.…
It is an honor and a privilege to be selected to present at the American Society of Hematology Conference. Dr.…
At ASH 2016, experts from across the nation discuss how genetic testing is affecting the evolution of treatment for MPNs.…
We continue to provide informational videos for our Spanish speaking community and welcome Dr. Luis Raez, MD FACP FCCP, Chief…
In this presentation from Lymphoma & Myeloma 2016, Dr. Joseph R. Mikhael discusses the best induction therapy for transplant-eligible myeloma…
In this presentation from Lymphoma & Myeloma 2016, Dr. Philippe Moreau argues that myeloma patients should receive maintenance therapy indefinitely…
In this presentation from Lymphoma & Myeloma 2016, Dr. James R. Berenson argues for no or limited maintenance therapy in…
In this presentation from Lymphoma & Myeloma 2016, Dr. Kenneth C. Anderson discusses new paradigms and therapies in the treatment…
In this presentation from Lymphoma & Myeloma 2016, Dr. Maria-Victoria Mateos discusses how to assess who has smoldering myeloma and…
In this presentation from Lymphoma & Myeloma 2016, Dr. C. Ola Landgren provides an update on new approaches and the…
In this presentation from Lymphoma & Myeloma 2016, Dr. Scott A. Ely elucidates a fresh look at myeloma proliferation. Earn…
In this presentation from Lymphoma & Myeloma 2016, Dr. Raphael Fonseca discusses the challenges in defining an actionable approach to…
In this Key Insights activity, Drs. Corey J. Langer, MD and Joshua Bauml discuss the key take-home points from the…
At ASH 2016, MPN experts from around the nation came together to review current and developing therapies for MPNs. Dr.…
Theodore S. Hong, MD of Massachusetts General Hospital talks about the Promising Results for Folfirinox with Losartan in Locally Advanced…
Theodore S. Hong, MD of Massachusetts General Hospital outlines a Phase II Study of Folfirinox followed my Individualized Radiation Therapy…
Theodore S. Hong, MD of Massachusetts General Hospital outlines how Metformin may increase Overall Survival in Patients with Resectable Pancreatic…
Theodore S. Hong, MD of Massachusetts General Hospital discusses the Secondary Analysis of RTOG 9704 Gemcitabine versus 5-FU in Resectable…
Theodore S. Hong, MD of Massachusetts General Hospital outlines how Novel Agents and Proton Beam Therapy studies may be on…
Theodore S. Hong, MD of Massachusetts General Hospital says that a 2nd Opinion from Surgeon Helpful in the Management of…
John L. Marshall of Lombardi Comprehensive Cancer Institute discusses how the results of the RESORCE Trial will impact treatment for…
John L. Marshall, MD of Lombardi Comprehensive Cancer Center gives his perspective on how to choose molecular tests for treating…
John L. Marshall, MD of Lombardi Comprehensive Cancer Center gives his take on how to integrate genetic mutations, and left…
John L. Marshall MD, of Lombardi Comprehensive Cancer Center discusses how checkpoint inhibitors are being integrated into gastrointestinal cancers at…
John L. Marshall of Lombardi Comprehensive Cancer Center discusses how vaccines can be used to broaden the use of immunotherapies…
Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute gives his perspective on considerations when treating a newly diagnosed…
Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute gives his perspective on how to use both TAS-102 and…
Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute discusses whether or not resected pancreatic cancer patients should be…
Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute gives his take on choosing molecular tests for treatment for…
Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute discusses how healthcare professionals are integrating immunotherapy in existing treatment…
Stevin Lin, MD, PhD of MD Anderson Cancer Center highlights how Proton Therapy May Have Benefits to Immunotherapy Treatments from…
Stevin Lin, MD, PhD of MD Anderson Cancer Center discusses how using Proton therapy can lower Lymphopenia in esophageal cancer…
Stevin Lin, MD, PhD of MD Anderson Cancer Center outlines the next steps for research and clinical trials associated to…
Stevin Lin, MD, PhD of MD Anderson discusses the costs of Proton Therapy versus the cost of IMRT and 3d…
Alan P. Venook, MD, FAnnual Meeting of Helen Diller Family Comprehensive Cancer Center discusses how the 80405 study in CRC…
Alan P. Venook, MD, FAnnual Meeting of Helen Diller Family Comprehensive Cancer Center gives his take on ordering which molecular…
Alan P. Venook, MD, FAnnual Meeting of Helen Diller Family Comprehensive Cancer Center gives his perspective on how to use…